Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 51 - 60 of 111 for ShangPharma. (0.07 seconds)

Avenue Capital Group has teamed up with China Medical...
BioBay, the Suzhou life science park, formed a cancer...
Xizang Haisco Pharma, a Tibetan TCM company, staged a...
Mindray Medical paid $35.5 million for a controlling...
WuXi PharmaTech is forming a JV with PRA, a US-based...
BioPacific Investors, an US group of angel investors, has...
Dr. Arthur Taveras, a US pharma executive with 24 years...
ChemPartner, the preclinical CRO/CMO division of China's...
WuXi PharmaTech, through its WuXi NextCODE Genomics...
ChemPartner, the CRO component of China-US...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here